References
- Erdogan M, Sayin N, Yildiz Ekinci D, Bayramoglu S. Bilateral posterior scleritis associated with giant cell arteritis: A case report. Ocul Immunol Inflamm. 2017;15:1–4.
- Cavallini GM, Volante V, Bigliardi MC, Mascia MT, Forlini M. Bilateral posterior scleritis as a presenting manifestation of giant cell arteritis: A case report. Can J Ophthalmol. 2014;49:141–143. doi:10.1016/j.jcjo.2013.10.004.
- Stone JH, Tuckwell K, Dimonaco S, et al. Trial of tocilizumab in giant-cell arteritis. N Engl J Med. 2017;377:317–328. doi:10.1056/NEJMoa1613849.
- Sammel AM, Fraser CL. Update on giant cell arteritis. Curr Opin Ophthalmol. 2018;29:520–527. doi:10.1097/ICU.0000000000000528.
- Sainz-de-la-Maza M, Molins B, Mesquida M, et al. Interleukin-22 serum levels are elevated in active scleritis. Acta Ophthalmol. 2016;94:395–399. doi:10.1111/aos.13005.